Sophie Lanzkron

Associate Professor

1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Innovations in Targeted Anti-Adhesion Treatment for Sickle Cell Disease

Kanter, J. & Lanzkron, S., Jan 1 2020, In : Clinical pharmacology and therapeutics. 107, 1, p. 140-146 7 p.

Research output: Contribution to journalReview article

2019

2019 sickle cell disease guidelines by the American Society of Hematology: Methodology, challenges, and innovations

Hassan Murad, M., Liem, R. I., Lang, E. S., Akl, E. A., Meerpohl, J. J., DeBaun, M. R., Tisdale, J. F., Brandow, A. M., Lanzkron, S. M., Chou, S. T., Webb, S. & Mustafa, R. A., Jan 1 2019, In : Blood Advances. 3, 23, p. 3945-3950 6 p.

Research output: Contribution to journalReview article

Open Access

Overcoming challenges of venous thromboembolism in sickle cell disease treatment

Ogunsile, F. J., Naik, R. & Lanzkron, S., Mar 4 2019, In : Expert review of hematology. 12, 3, p. 173-182 10 p.

Research output: Contribution to journalReview article

2016

Improving inpatient care for individuals with sickle cell disease using the project ECHO model

Stewart, R., Whiteman, L. N., Strouse, J., Carroll, C. P. & Lanzkron, S., Sep 1 2016, In : Southern Medical Journal. 109, 9, p. 568-569 2 p.

Research output: Contribution to journalReview article

Need for specialized centers to provide acute care to adults with sickle cell disease

Lanzkron, S., Sep 1 2016, In : Southern Medical Journal. 109, 9, p. 566-567 2 p.

Research output: Contribution to journalReview article

2014

Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members

Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., Tanabe, P. J., Ware, R. E., Murad, M. H., Goldsmith, J. C., Ortiz, E., Fulwood, R., Horton, A. & John-Sowah, J., Sep 10 2014, In : JAMA - Journal of the American Medical Association. 312, 10, p. 1033-1048 16 p.

Research output: Contribution to journalReview article

2012
2011

The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease

Strouse, J. J., Lanzkron, S. & Urrutia, V., Dec 1 2011, In : Expert review of hematology. 4, 6, p. 597-606 10 p.

Research output: Contribution to journalReview article

2008

Hydroxyurea for the treatment of sickle cell disease.

Segal, J. B., Strouse, J. J., Beach, M. C., Haywood, C., Witkop, C., Park, H., Wilson, R. F., Bass, E. B. & Lanzkron, S., Mar 1 2008, In : Evidence report/technology assessment. 165, p. 1-95 95 p.

Research output: Contribution to journalReview article

2007

NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea

Liebelt, E. L., Balk, S. J., Faber, W., Fisher, J. W., Hughes, C. L., Lanzkron, S. M., Lewis, K. M., Marchetti, F., Mehendale, H. M., Rogers, J. M., Shad, A. T., Skalko, R. G., Stanek, E. J. & Shelby, M. D., Aug 1 2007, In : Birth Defects Research Part B - Developmental and Reproductive Toxicology. 80, 4, p. 259-366 108 p.

Research output: Contribution to journalReview article

1996

Management of patients who require invasive procedures immediately following thrombolytic therapy

Lanzkron, S. M. & Bell, W. R., Jan 1 1996, In : Clinical and Applied Thrombosis/Hemostasis. 2, 3, p. 158-163 6 p.

Research output: Contribution to journalReview article